Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin D Deane

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
The Lancet. Rheumatology|February 1, 2026
Early screening for rheumatoid arthritis-associated interstitial lung disease: statistical nuances challenge the role of disease activity - Authors' replyGregory C McDermott, Misti L Paudel, Marcy B Bolster, et al.
Cancers|November 14, 2023
Antinuclear Antibodies Are Associated with an Increased Risk of Diffuse Large B-Cell LymphomaEleanor Frost, Jonathan N Hofmann, Wen-Yi Huang, et al.
Frontiers in Lupus|July 2, 2026
Oral Contraceptive Pill Use is Associated with Lower Levels of Plasma Calprotectin in Premenopausal WomenDaniele Marcy, Caroline Maretz, Kristin Sturm, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2018
Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritisNithya Lingampalli, Jeremy Sokolove, Lauren J Lahey, et al.
Clinical Rheumatology|March 3, 2009
Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RAAlison M Gizinski, Margherita Mascolo, Jennifer L Loucks, et al.
Nature Reviews. Rheumatology|August 17, 2018
Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destructionV Michael Holers, M Kristen Demoruelle, Kristine A Kuhn, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Detecting change-points in preclinical rheumatoid arthritis biomarkers using Bayesian multivariate segmented regressionYonatan F Wolde, Alexandria M Jensen, Brandie D Wagner, et al.
Arthritis Research & Therapy|June 7, 2021
Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritisM Kristen Demoruelle, Hong Wang, Ryan L Davis, et al.
Current Treatment Options in Rheumatology|December 7, 2020
Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatmentSicong Huang, Vanessa L Kronzer, Paul F Dellaripa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2022
Prediction of Erosive Disease Development by Antimitochondrial Antibodies in Rheumatoid ArthritisRichard E Moore, Ting Wang, Bhargavi Duvvuri, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
The Lancet. Rheumatology|February 1, 2026
Early screening for rheumatoid arthritis-associated interstitial lung disease: statistical nuances challenge the role of disease activity - Authors' replyGregory C McDermott, Misti L Paudel, Marcy B Bolster, et al.
Cancers|November 14, 2023
Antinuclear Antibodies Are Associated with an Increased Risk of Diffuse Large B-Cell LymphomaEleanor Frost, Jonathan N Hofmann, Wen-Yi Huang, et al.
Frontiers in Lupus|July 2, 2026
Oral Contraceptive Pill Use is Associated with Lower Levels of Plasma Calprotectin in Premenopausal WomenDaniele Marcy, Caroline Maretz, Kristin Sturm, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2018
Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritisNithya Lingampalli, Jeremy Sokolove, Lauren J Lahey, et al.
Clinical Rheumatology|March 3, 2009
Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RAAlison M Gizinski, Margherita Mascolo, Jennifer L Loucks, et al.
Nature Reviews. Rheumatology|August 17, 2018
Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destructionV Michael Holers, M Kristen Demoruelle, Kristine A Kuhn, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Detecting change-points in preclinical rheumatoid arthritis biomarkers using Bayesian multivariate segmented regressionYonatan F Wolde, Alexandria M Jensen, Brandie D Wagner, et al.
Arthritis Research & Therapy|June 7, 2021
Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritisM Kristen Demoruelle, Hong Wang, Ryan L Davis, et al.
Current Treatment Options in Rheumatology|December 7, 2020
Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatmentSicong Huang, Vanessa L Kronzer, Paul F Dellaripa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2022
Prediction of Erosive Disease Development by Antimitochondrial Antibodies in Rheumatoid ArthritisRichard E Moore, Ting Wang, Bhargavi Duvvuri, et al.
Pageof 18